NEAT1 and neoplasm: In particular, NEAT1 inhibition by short hairpin RNAs (shRNAs) significantly enhances the effectiveness of sorafenib, leading to prompted drug-induced cell death and significantly smaller tumor mass in nude mice compared to treatment with sorafenib alone [111, 112].